EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overcoming BET ‐inhibitor JQ1 resistance in aggressive non‐small cell lung cancer by inducing ferroptosis via inhibition of the BRD2 – FTH1 axis

Stefania Scicchitano, Cinzia Garofalo, Beatrice Stella, Gianluca Santamaria, Flora Cozzolino, Vittoria Monaco, Flavia Biamonte, Maria Monti, Eleonora Vecchio iD, Maria Concetta Faniello iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Stefania Scicchitano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Italy. Hauptthemen laut MEDLINE: Azepines, Triazoles, Carcinoma, Non-Small-Cell Lung, Ferroptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies emphasize the involvement of the nuclear H ferritin subunit (FTH1; also known as ferritin heavy chain) in DNA protection from oxidative damage and transcriptional regulation. Bromodomain and extra‐terminal domain (BET) proteins act as epigenome readers for transcriptional regulation. Among them, the role of bromodomain‐containing protein 2 (BRD2) in non‐small cell lung carcinoma (NSCLC) remains unclear. Moreover, the clinical utilization of BET bromodomain inhibition is severely limited by different sensitivities among NSCLC subtypes. This study provides the first evidence of nuclear BRD2‐FTH1 functional interplay. Nuclear FTH1 is associated with BRD2, not bromodomain‐containing protein 4 (BRD4), in a panel of NSCLC cell lines and affects BRD2 protein stability only in more aggressive types of NSCLC cells. In addition, the protective function of FTH1 was abrogated in FTH1‐ silenced cells that are resistant to synthetic BET bromodomain inhibitor JQ1 (a thieno‐triazolo‐1,4‐diazepine) but not in JQ1‐sensitive cells, leading to an increase in mortality. Then, the potential mechanism by which the combination of JQ1 with FTH1 silencing induces cell death was explored. The results show that ferroptosis is involved in the anticancer effect of JQ1 upon FTH1 silencing only in JQ1‐insensitive cells. Moreover, the expression of ferroptosis‐associated genes glutathione peroxidase 4 ( GPX4 ), solute carrier family 7 member 11 ( SLC7A11 ) and solute carrier family 3 member 2 ( SLC3A2 ) was downregulated under JQ1 treatment only after FTH1 silencing, indicating that the BRD2 inhibition due to the co‐treatment could regulate the expression of ferroptosis‐associated genes. In summary, for the first time, our data suggest that FTH1 silencing may serve as an effective anti‐tumor strategy to enhance the activity of JQ1, acting to overcome the chemotherapy resistance in more aggressive NSCLCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzepinesTriazolesCarcinoma, Non-Small-Cell LungFerroptosisLung NeoplasmsDrug Resistance, NeoplasmProtein Serine-Threonine KinasesHumansCell Line, TumorGene Expression Regulation, NeoplasticTranscription FactorsBromodomain Containing ProteinsFerritinsOxidoreductases

Stichwörter der Autor:innen

BRD2FTH1JQ1ferroptosislung canceroxidative damage

Substanzen

Azepines(+)-JQ1 compoundTriazolesBRD2 protein, humanFTH1 protein, humanProtein Serine-Threonine KinasesTranscription FactorsBromodomain Containing ProteinsFerritinsOxidoreductases

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Italy.
  • Department of Chemical Sciences, Federico II University of Naples and CEINGE Advanced Biotechnologies Franco Salvatore, Italy.

ORCID-Profile: Eleonora Vecchio, Maria Concetta Faniello

Zitieren

APA

Scicchitano, S., Garofalo, C., Stella, B., Santamaria, G., Cozzolino, F., Monaco, V., Biamonte, F., Monti, M., Vecchio, E., & Faniello, M. C. (2025). Overcoming BET ‐inhibitor JQ1 resistance in aggressive non‐small cell lung cancer by inducing ferroptosis via inhibition of the BRD2 – FTH1 axis. The FEBS Journal. https://doi.org/10.1111/febs.70191

Vancouver

Scicchitano S, Garofalo C, Stella B, Santamaria G, Cozzolino F, Monaco V, et al. Overcoming BET ‐inhibitor JQ1 resistance in aggressive non‐small cell lung cancer by inducing ferroptosis via inhibition of the BRD2 – FTH1 axis. The FEBS Journal. 2025. doi:10.1111/febs.70191

BibTeX
@article{Scicchitano2025,
  author = {Scicchitano, Stefania and Garofalo, Cinzia and Stella, Beatrice and Santamaria, Gianluca and Cozzolino, Flora and Monaco, Vittoria and Biamonte, Flavia and Monti, Maria and Vecchio, Eleonora and Faniello, Maria Concetta},
  title = {Overcoming BET ‐inhibitor JQ1 resistance in aggressive non‐small cell lung cancer by inducing ferroptosis via inhibition of the BRD2 – FTH1 axis},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70191}
}
Kostenlos starten →